In the latest close session, CRISPR Therapeutics AG (CRSP) was down 1.81% at $60.77. This change lagged the S&P 500's daily ...

In a study published in Science Translational Medicine, a team of researchers led by Dr. Wang Yu from the Shenzhen Institutes ...

One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ...

Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...

There's more to young biopharma companies than their numbers, but those numbers are still an important part of each ...

A new CRISPR-based method increases protein production in a targeted manner, bringing new insights to stem cell biology and ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Persistence Market Research, a leading management consulting firm, has released this update on the gene editing market. Gene ...

When standard leukaemia treatments failed, 13-year-old Alyssa Tapley was told she had only weeks left – but then she was ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...